BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11899821)

  • 1. [Clinical, biochemical, and morphological characteristics of chronic hepatitis with various etiology].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2002; 74(2):35-7. PubMed ID: 11899821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic hepatitis: indicators of disease activity].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2000; 72(2):17-8. PubMed ID: 10717917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical characterization of viral hepatitis in humans, using and not using narcotics].
    Tomilka GS; Zhuravlev IaA; Gordinskaia NM
    Ter Arkh; 2002; 74(11):6-10. PubMed ID: 12498114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute alcoholic hepatitis (fatty liver hepatitis)].
    Sohnack H
    Wien Med Wochenschr; 1972 Jul; 122(30):460-4. PubMed ID: 5065650
    [No Abstract]   [Full Text] [Related]  

  • 5. The liver in acquired immune deficiency syndrome: emphasis on patients with intravenous drug abuse.
    Dworkin BM; Stahl RE; Giardina MA; Wormser GP; Weiss L; Jankowski R; Rosenthal WS
    Am J Gastroenterol; 1987 Mar; 82(3):231-6. PubMed ID: 3826029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological liver changes of chronic hepatitis C in antiretroviral-naive HIV-infected patients].
    Grabczewska E; Pawłowska M
    Przegl Epidemiol; 2005; 59(2):423-30. PubMed ID: 16190550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology of chronic diffuse liver damages].
    Nikushkina IN; Maev IV; Samsonov AA; Andreev NG; Salova LM
    Eksp Klin Gastroenterol; 2007; (5):36-9, 164. PubMed ID: 18389595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of chronic hepatitis. Correlation of clinical, biochemical and histological parameters in 32 cases.
    Gayotto LC; Strauss E; Alves VA; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):288-93. PubMed ID: 6200913
    [No Abstract]   [Full Text] [Related]  

  • 9. [The different biochemical course of HBsAg-negative and HBsAg-positive hepatitis (author's transl)].
    Strohm WD; Hossenfelder E; Stille W
    Z Gastroenterol; 1978 Jan; 16(1):13-23. PubMed ID: 74913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequelae of viral hepatitis. Functional profile].
    Konecny A; Rolli R
    Minerva Med; 1972 Jul; 63(52):2834-9. PubMed ID: 5049876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatopathies in concomitance of chronic drug and alcoholic intoxications].
    Paukov VS; Ermakova OM; Kostornaia IV
    Arkh Patol; 2008; 70(5):25-9. PubMed ID: 19137779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach.
    Madan K; Batra Y; Panda SK; Dattagupta S; Hazari S; Jha JK; Acharya SK
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1291-9. PubMed ID: 15482537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.
    Kuper H; Ye W; Broomé U; Romelsjö A; Mucci LA; Ekbom A; Adami HO; Trichopoulos D; Nyrén O
    Hepatology; 2001 Oct; 34(4 Pt 1):714-8. PubMed ID: 11584367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
    Cetin K; Sabahattin K; Kadir D; Ahmet D; Ziyaettin D; Selim B; Mürüvvet B; Fatih B; Güngör B; Zeynel M; Yilmaz C; Atilla O
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcv-ccxcvii. PubMed ID: 15244206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis and drug abuse].
    Haensch G; Stalder GA
    Dtsch Med Wochenschr; 1972 Oct; 97(43):1623-6. PubMed ID: 5083085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic active hepatitis in alcoholics].
    Laskus T; Cianciara J; Lupa E; Musabbir M; Babiuch L
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):327-30. PubMed ID: 2235719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.